FDA adcomms to review data on long-term opioid use, overdosesnews2025-05-01T19:39:25+00:00May 1st, 2025|Endpoints News|
Experts refute RFK Jr.’s claim that placebo-controlled trials for vaccines are newnews2025-05-01T18:58:23+00:00May 1st, 2025|Endpoints News|
FDA approves Satsuma’s migraine nasal spray after rejection in 2024news2025-05-01T14:55:41+00:00May 1st, 2025|Endpoints News|
More FDA staff leave, following broad firings at drug agencynews2025-04-30T19:25:03+00:00April 30th, 2025|Endpoints News|
FDA approves Johnson & Johnson’s rare disease drug that’s expected to compete with argenx and UCBnews2025-04-30T13:22:14+00:00April 30th, 2025|Endpoints News|
FDA approves Abeona’s skin disease cell therapynews2025-04-29T15:06:37+00:00April 29th, 2025|Endpoints News|
FDA won’t reorganize medical product centers, Makary says in interviewnews2025-04-29T14:56:35+00:00April 29th, 2025|Endpoints News|
FDA delays decision date for small biotech, raising questions about impact of agency cutsnews2025-04-29T10:00:08+00:00April 29th, 2025|Endpoints News|
Vaxart says stop-work order was lifted on next-gen Covid vaccine news2025-04-28T18:43:51+00:00April 28th, 2025|Endpoints News|
Novavax responds to FDA’s request for new Covid vaccine trialnews2025-04-28T17:48:21+00:00April 28th, 2025|Endpoints News|
